Background: Virtual reality (VR) technology is a relatively new rehabilitation tool that can deliver a combination of cognitive and motor training for fall prevention. The attitudes of older people to such training are currently unclear. Objective: This study aimed to investigate: (1) the attitudes of fall-prone older people towards fall prevention exercise with and without VR; (2) attitudinal changes after intervention with and without VR; and (3) user satisfaction following fall prevention exercise with and without VR. Methods: A total of 281 fall-prone older people were randomly assigned to an experimental group receiving treadmill training augmented by VR (TT+VR, n = 144) or a control group receiving treadmill training alone (TT, n = 137). Two questionnaires were used to measure (1) attitudes towards fall prevention exercise with and without VR (AQ); and (2) user satisfaction (USQ). AQ was evaluated at baseline and after intervention. USQ was measured after intervention only. Results: The AQ revealed that most participants had positive attitudes towards fall prevention exercise at baseline (82.2%) and after intervention (80.6%; p = 0.144). In contrast, only 53.6% were enthusiastic about fall prevention exercise with VR at baseline. These attitudes positively changed after intervention (83.1%; p < 0.001), and 99.2% indicated that they enjoyed TT+VR. Correlation analyses showed that postintervention attitudes were strongly related to user satisfaction (USQ: r = 0.503; p < 0.001). Conclusions: Older people's attitudes towards fall prevention exercise with VR were positively influenced by their experience. From the perspective of the user, VR is an attractive training mode, and thus improving service provision for older people is important.

Keywords:
Virtual reality, Exercise, Attitude
1.
Tinetti ME, Speechley M, Ginter SF: Risk factors for falls among elderly persons living in the community. N Engl J Med 1988;319:1701-1707.
2.
Allen NE, Schwarzel AK, Canning CG: Recurrent falls in Parkinson's disease: a systematic review. Parkinsons Dis 2013;2013:906274.
3.
Liu-Ambrose TY, Ashe MC, Graf P, Beattie BL, Khan KM: Increased risk of falling in older community-dwelling women with mild cognitive impairment. Phys Ther 2008;88:1482-1491.
4.
Gillespie LD, Robertson MC, Gillespie WJ, Sherrington C, Gates S, Clemson LM, Lamb SE: Interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev 2012;9:CD007146.
5.
Keshner EA: Virtual reality and physical rehabilitation: a new toy or a new research and rehabilitation tool? J Neuroeng Rehabil 2004;1:8.
6.
Goble DJ, Cone BL, Fling BW: Using the Wii Fit as a tool for balance assessment and neurorehabilitation: the first half decade of “Wii-search.” J Neuroeng Rehabil 2014;11:12.
7.
Pietrzak E, Cotea C, Pullman S: Using commercial video games for falls prevention in older adults: the way for the future? J Geriatr Phys Ther 2014;37:166-177.
8.
Toril P, Reales JM, Mayas J, Ballesteros S: Video game training enhances visuospatial working memory and episodic memory in older adults. Front Hum Neurosci 2016;10:206.
9.
Dockx K, Van den Bergh V, Bekkers EMJ, Ginis P, Rochester L, Hausdorff JM, Mirelman A, Nieuwboer A: Virtual reality for rehabilitation in Parkinson's disease. Cochrane Database Syst Rev 2013;10:CD010760.
10.
Mirelman A, Rochester L, Maidan I, Del Din S, Alcock L, Nieuwhof F, Rikkert MO, Bloem BR, Pelosin E, Avanzino L, et al: Addition of a non-immersive virtual reality component to treadmill training to reduce fall risk in older adults (V-TIME): a randomised controlled trial. Lancet 2016;388:1170-1182.
11.
Mirelman A, Rochester L, Reelick M, Nieuwhof F, Pelosin E, Abbruzzese G, Dockx K, Nieuwboer A, Hausdorff JM: V-TIME: a treadmill training program augmented by virtual reality to decrease fall risk in older adults: study design of a randomized controlled trial. BMC Neurol 2013;13:15.
12.
Folstein MF, Folstein SE, McHugh PR: “Mini-mental state.” A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
13.
Morris JC: Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type. Int Psychogeriatr 1997;9(suppl 1):173-176; discussion 177-178.
14.
Hughes AJ, Daniel SE, Kilford L, Lees AJ: Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-184.
15.
Hoehn MM, Yahr MD: Parkinsonism: onset, progression and mortality. Neurology 1967;17:427-442.
16.
World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects. Bull World Health Organ 2001;79:373-374.
17.
Demers L, Weiss-Lambrou R, Ska B: Development of the Quebec User Evaluation of Satisfaction with assistive Technology (QUEST). Assist Technol 1996;8:3-13.
18.
Yardley L, Beyer N, Hauer K, Kempen G, Piot-Ziegler C, Todd C: Development and initial validation of the Falls Efficacy Scale-International (FES-I). Age Ageing 2005;34:614-619.
19.
Bunn F, Dickinson A, Barnett-Page E, Mcinnes E, Horton K: A systematic review of older people's perceptions of facilitators and barriers to participation in falls-prevention interventions. Ageing Soc 2008;28:449-472.
20.
Hughes K, van Beurden E, Eakin EG, Barnett LM, Patterson E, Backhouse J, Jones S, Hauser D, Beard JR, Newman B: Older persons' perception of risk of falling: implications for fall-prevention campaigns. Am J Public Health 2008;98:351-357.
21.
Faes MC, Reelick MF, Joosten-Weyn Banningh LW, Gier M, Esselink RA, Olde Rikkert MG: Qualitative study on the impact of falling in frail older persons and family caregivers: foundations for an intervention to prevent falls. Aging Ment Health 2010;14:834-842.
22.
Ellis T, Boudreau JK, DeAngelis TR, Brown LE, Cavanaugh JT, Earhart GM, Ford MP, Foreman KB, Dibble LE: Barriers to exercise in people with Parkinson disease. Phys Ther 2013;93:628-636.
23.
Forkan R, Pumper B, Smyth N, Wirkkala H, Ciol MA, Shumway-Cook A: Exercise adherence following physical therapy intervention in older adults with impaired balance. Phys Ther 2006;86:401-410.
24.
Resnick B, Spellbring AM: Understanding what motivates older adults to exercise. J Gerontol Nurs 2000;26:34-42.
25.
Lange BS, Requejo P, Flynn SM, Rizzo AA, Valero-Cuevas FJ, Baker L, Winstein C: The potential of virtual reality and gaming to assist successful aging with disability. Phys Med Rehabil Clin N Am 2010;21:339-356.
26.
Marivan K, Boully C, Benveniste S, Reingewirtz S, Rigaud AS, Kemoun G, Bloch F: Rehabilitation of the psychomotor consequences of falling in an elderly population: a pilot study to evaluate feasibility and tolerability of virtual reality training. Technol Health Care 2016;24:169-175.
27.
Smith PL, Ragan TJ: Instructional Design. New York, John Wiley & Sons, 1999.
28.
Lewis GN, Rosie JA: Virtual reality games for movement rehabilitation in neurological conditions: how do we meet the needs and expectations of the users? Disabil Rehabil 2012;34:1880-1886.
29.
Lyons EJ: Cultivating engagement and enjoyment in exergames using feedback, challenge, and rewards. Games Health J 2015;4:12-18.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.